• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格雷夫斯眼病中的眼睑退缩和提上睑肌腱膜缺损

Lid retraction and levator aponeurosis defects in Graves' eye disease.

作者信息

Frueh B R, Musch D C, Garber F W

出版信息

Ophthalmic Surg. 1986 Apr;17(4):216-20.

PMID:3754942
Abstract

Vertical palpebral fissure determinants and lid crease height were measured in patients with Graves' eye disease (GED) and in normal subjects. The fissure and crease height are positively correlated with exophthalmometer readings in each group. Compensatory levator aponeurosis defects are shown to occur in patients with GED. These, along with the effect of exophthalmos on the lower lid position, the observation that the lower lid is closer to the inferior limbus than the upper lid is to the superior limbus in normal subjects, and the effect of contracture of the inferior rectus on the lower lid position, explain why inferior scleral show is found to be greater than superior scleral show in patients with GED. Thus, lid retractor surgery in GED patients should be performed only after the palpebral fissure, levator function, and lid crease height stabilize, and after any contemplated surgery that would alter the exophthalmos and extraocular muscles has been performed.

摘要

对格雷夫斯眼病(GED)患者和正常受试者测量了垂直睑裂决定因素和睑裂高度。在每组中,睑裂和睑裂高度与眼球突出计读数呈正相关。结果显示,GED患者存在代偿性提上睑肌腱膜缺损。这些因素,连同眼球突出对下睑位置的影响、正常受试者中下睑比上睑更靠近下角膜缘的观察结果以及下直肌挛缩对下睑位置的影响,解释了为什么在GED患者中发现下巩膜暴露大于上巩膜暴露。因此,GED患者的眼睑退缩手术应仅在睑裂、提上睑肌功能和睑裂高度稳定后,以及在任何考虑进行的会改变眼球突出和眼外肌的手术完成后进行。

相似文献

1
Lid retraction and levator aponeurosis defects in Graves' eye disease.格雷夫斯眼病中的眼睑退缩和提上睑肌腱膜缺损
Ophthalmic Surg. 1986 Apr;17(4):216-20.
2
The effects of Graves' eye disease on levator muscle function.格雷夫斯眼病对提上睑肌功能的影响。
Ophthalmic Surg. 1986 Mar;17(3):142-5.
3
Lid protractor force generation in Graves' eye disease.格雷夫斯眼病中眼睑量角器肌力的产生
Ophthalmology. 1986 Jan;93(1):8-13. doi: 10.1016/s0161-6420(86)33786-2.
4
Modified levator aponeurosis recession for upper eyelid retraction in Graves' disease.
Ophthalmic Surg. 1991 Jun;22(6):313-7.
5
Exophthalmometer readings in patients with Graves' eye disease.格雷夫斯眼病患者的眼球突出度测量值。
Ophthalmic Surg. 1986 Jan;17(1):37-40.
6
Strategies for simultaneous double eyelid blepharoplasty in Asian patients with congenital blepharoptosis.亚洲先天性上睑下垂患者同期双眼皮成形术的策略
Aesthetic Plast Surg. 2008 Jan;32(1):66-71. doi: 10.1007/s00266-007-9050-5.
7
Graded full-thickness anterior blepharotomy for upper eyelid retraction.用于上睑退缩的分级全层前路睑裂切开术。
Trans Am Ophthalmol Soc. 2003;101:67-73; discussion 73-5.
8
Changes of the lid fissure after surgery on horizontal extraocular muscles.水平眼外肌手术后睑裂的变化。
Am J Ophthalmol. 2005 Dec;140(6):1145-6. doi: 10.1016/j.ajo.2005.06.060.
9
Levator function revisited: a two-phase assessment of lid movement to better identify levator-superior rectus synkinesis.重新审视提上睑肌功能:评估眼睑运动的两阶段方法,以更好地识别提上睑肌-上直肌协同运动。
Br J Ophthalmol. 2010 Feb;94(2):229-32. doi: 10.1136/bjo.2008.147124. Epub 2009 Aug 18.
10
[Surgical treatment of the sequelae of Basedow's ophthalmopathy].[突眼性甲状腺肿眼病后遗症的外科治疗]
J Fr Ophtalmol. 1985;8(3):227-37.

引用本文的文献

1
Nonsurgical management of upper eyelid retraction in thyroid eye disease.甲状腺眼病上睑退缩的非手术治疗
Taiwan J Ophthalmol. 2023 May 23;14(4):548-553. doi: 10.4103/tjo.TJO-D-23-00043. eCollection 2024 Oct-Dec.
2
Percutaneous triamcinolone injection for upper eyelid retraction in thyroid eye disease.经皮注射曲安奈德治疗甲状腺眼病上睑退缩
Front Ophthalmol (Lausanne). 2024 May 17;4:1388197. doi: 10.3389/fopht.2024.1388197. eCollection 2024.
3
Graves' Eye Disease: Clinical and Radiological Diagnosis.格雷夫斯眼病:临床与影像学诊断
Biomedicines. 2023 Jan 22;11(2):312. doi: 10.3390/biomedicines11020312.
4
Thicknesses of the retinal layers in patients with Graves' disease with or without orbitopathy.格雷夫斯病伴或不伴眼病患者的视网膜各层厚度。
Int Ophthalmol. 2022 Nov;42(11):3397-3405. doi: 10.1007/s10792-022-02339-w. Epub 2022 May 12.
5
Absent Bell's phenomenon in patients with thyroid eye disease.甲状腺眼病患者的 Bell 现象缺失。
BMC Ophthalmol. 2021 Oct 11;21(1):361. doi: 10.1186/s12886-021-02107-x.
6
Blepharoptosis in thyroid eye disease: etiopathogenesis, clinical features and correlation with thyroid eye disease.甲状腺相关眼病中的上睑下垂:发病机制、临床特征及与甲状腺眼病的相关性。
Int Ophthalmol. 2022 Jan;42(1):13-18. doi: 10.1007/s10792-021-01992-x. Epub 2021 Aug 4.
7
Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm.甲状腺眼病:一种新型疗法如何改变治疗模式。
Ther Clin Risk Manag. 2019 Nov 11;15:1305-1318. doi: 10.2147/TCRM.S193018. eCollection 2019.
8
Relationships between eyelid position and levator-superior rectus complex and inferior rectus muscle in patients with Graves' orbitopathy with unilateral upper eyelid retraction.Graves眼病单侧上睑退缩患者眼睑位置与提上睑肌-上直肌复合体及下直肌之间的关系
Graefes Arch Clin Exp Ophthalmol. 2018 Oct;256(10):2001-2008. doi: 10.1007/s00417-018-4056-z. Epub 2018 Jun 29.
9
Rituximab in the Treatment of Thyroid Eye Disease: A Review.利妥昔单抗治疗甲状腺眼病:综述
Neuroophthalmology. 2015 Jun 17;39(3):109-115. doi: 10.3109/01658107.2015.1039140. eCollection 2015 Jun.
10
Thyroid associated orbitopathy.甲状腺相关眼病。
Indian J Ophthalmol. 2012 Mar-Apr;60(2):87-93. doi: 10.4103/0301-4738.94048.